Table 1. Baseline characteristics of patients with AAV.
Total | Renal | Non-renal | P value (Renal vs Non-renal) |
|
---|---|---|---|---|
Number | 51 | 41 | 10 | |
Age (years) | 67.6 ± 1.8 | 68.6 ± 1.9 | 63.7 ± 5.3 | 0.4 |
Sex (M/F) | 24/27 | 20/21 | 4/6 | |
MPA/GPA/EPGA | 43/6/2 | 35/6/0 | 8/0/2 | |
MPO+/PR3+ | 46/5 | 36/5 | 10/0 | |
Onset | 40 | 30 | 10 | |
Focal/Crescentic/ Mixed/Sclerotic |
4/4/5/1 | 4/4/5/1 | - | |
Relapse | 5 | 5 | - | |
Remission | 6 | 6 | - | |
CRP (mg/dl) | 6.9 ± 0.7 | 7.1 ± 0.8 | 6.2 ± 1.4 | 0.61 |
sCr (mg/dl) | 2.05 ± 0.3 | 2.39 ± 0.35 | 0.63 ± 0.05 | <0.001 |
eGFR (mL/min/1.73m2) |
44.9 ± 4.2 | 34.5 ± 3.3 | 87.6 ± 7.5 | <0.001 |
U-Pro/Cr (g/gCr) | 1.08 ± 0.18 | 1.32 ± 0.21 | 0.16 ± 0.02 | <0.001 |
MPO: myeloperoxidase-ANCA. PR3: proteinase3-ANCA. CRP: C-reactive protein. L-FABP: L-type fatty acid-binding protein. NAG: N-acetyl-beta-glucosaminidase. MPA: microscopic polyangiitis. GPA: granulomatosis with polyangiitis. EPGA: eosinophilic granulomatosis with polyangiitis.